Apollo Hospitals Enterprise Limited · NSE:APOLLOHOSP

Apollo Hospitals Enterprise — Q2 FY27 Earnings Presentation

40 slides from Apollo Hospitals Enterprise's earnings presentation, Nov 4, 2026

  1. Slide 1: Apollo Hospitals Enterprise Limited exchange disclosure letter

    APOLLO HOSPITALS ENTERPRISE LIMITED CIN: L85110TN1979PLC008035 November 4, 2026 The Secretary, The Secretary, Bombay Stock Exchange Ltd (BSE) National Stock Exchange, Phiroze Jheejheebhoy Towers, Exchange Plaza, 5th Floor Dalal Street, Plot No.C/1, ‘G’ Block Mumbai – 400 001. Bandra – Kurla Complex

  2. Slide 2: Apollo Hospitals Enterprise Limited Earnings Update Q2 FY27

    Apollo Hospitals Enterprise Limited Earnings Update Q2 FY27 •

  3. Slide 3: Disclaimer

    Disclaimer The information contained in this presentation is provided by Apollo Hospitals Enterprise Limited (the “Company”) to you solely for your reference. This document is being given solely for your information and for your use and may not be retained by you and neither this presentation nor an

  4. Slide 4: Content

    Content Financial Performance Snapshot & Business Digital Health Segment wise Update & Pharmacy Distribution 4-9 (Apollo HealthCo) Consolidated Financials 11-12 Healthcare Services 14-23 Diagnostics & Retail Health (AHLL) 25-28 Digital Health & Pharmacy Distribution (Apollo HealthCo) 30-35 Annexure

  5. Slide 5: Financial Performance Snapshot Q2FY27

    Financial Performance Snapshot Q2FY27 (in ₹ Mio) Revenue Growth EBITDA(Post Ind AS) Margin Growth PAT Growth YoY(%) YoY(%) YoY(%) 38,998 9,365 20% 4,860 Healthcare Services 24.0% 12.5% 19% 23% Offline PD ^ 28,845 24% 2,057 7.1% 13% Apollo HealthCo ^PD:- Pharmacy Distribution Online PD^ & 1 4,012 23%

  6. Slide 6: Financial Performance Snapshot H1FY27

    Financial Performance Snapshot H1FY27 (in ₹ Mio) Revenue Growth EBITDA(Post Ind AS) Margin Growth PAT Growth YoY(%) YoY(%) YoY(%) 74,668 17,978 20% 9,649 Healthcare Services 22% 24.1% 12.9% 22% Offline PD ^ 55,132 23% 3,967 7.2% 14% Apollo HealthCo ^PD:- Pharmacy Distribution Online PD^ & 1 (323) Vs

  7. Slide 7: Largest Pan India Hospital Chain

    Largest Pan India Hospital Chain Capacity Operational Hospitals Census Beds1 Census Beds Overall Total 65 * 10,733 9,605 Delhi: 4 Noida: 1 Owned Hospitals 48 9,650 8,522 Bilaspur: 1 Kanpur: 1 Lucknow: 1 Managed Hospitals 6 806 806 Jaipur: 1 Day Surgery 277 277 (AHLL) 11 Jabalpur: 1 1Capacity beds in

  8. Slide 8: AHLL: Retail Health

    AHLL: Retail Health Apollo Health & Lifestyle Ltd Out-of-Hospital care 1. AHLL completed the transfer of its stake in ASPL (Cradle) and AFCPL (Fertility) to Kids Clinic India • Outpatient Clinics Limited on October 12, 2026. • Diagnostics • Day Surgery centers 2. Total Consideration: Rs 1,550 crs •

  9. Slide 9: AHL: India's Largest Omni-channel Healthcare Platform

    AHL| India’s Largest Omni-channel Healthcare Platform Apollo HealthCo Ltd Apollo 24|7 Apollo Telehealth* • I• Unmatched Size • Provides comprehensive remote healthcare • 51 Mn.+ Registered Users – ~ 8.7 Lacs Daily services. Active Users t, hi Manish - • Offers specialized telehealth solutions like 2

  10. Slide 10: Clinical Updates and New Initiatives

    Clinical Updates and New Initiatives o Robotic Surgery: Apollo Hospitals, Greams Road, Chennai, crossed 2,000 cumulative robotic-assisted orthopaedic surgeries across knee and hip replacements. o Advanced Stroke Care: Apollo Hospitals, Jayanagar, performed mechanical thrombectomy in a 72-year-old ma

  11. Slide 11: Consolidated Financials

    • Consolidated Financials Consolidated Financials © 2026 Apollo Hospitals Enterprise Ltd, All Rights Reserved 10

  12. Slide 12: Consolidated Financials Q2FY27

    Consolidated Financials Q2FY27 (` mio) Digital Health Healthcare Diagnostics & Overall Consolidated Revenue grew by 23% to ` 76,149 mio. ` Mio & Pharmacy Consol Services Retail Health Distribution Total Revenues 38,998 4,294 32,857 76,149 EBITDA grew by 29% to ` 11,910 mio. EBITDA (Pre 24|7 Cost) 9,

  13. Slide 13: Consolidated Financials H1FY27

    Consolidated Financials H1FY27 (` mio) Digital Health Healthcare Diagnostics & Overall Consolidated Revenue grew by 22% to ` 145,468 mio. ` Mio & Pharmacy Consol Services Retail Health Distribution Total Revenues 74,668 8,172 62,628 145,468 EBITDA grew by 29%to ` 22,678 mio. EBITDA (Pre 24|7 Cost) 1

  14. Slide 14: Healthcare Services Hospitals

    • Healthcare Services Hospitals © 2026 Apollo Hospitals Enterprise Ltd, All Rights Reserved 13

  15. Slide 15: Healthcare Services Financials

    Healthcare Services Financials (` mio) ` Mio Q2FY27 Q2FY26 YoY H1FY27 H1FY26 YoY Healthcare Services Revenue grew by 23% in Q2FY27 . No of Hospitals 48 45 48 45 Overall Volume grew by 14% (Established Units Volume grew by Operating beds 8,522 8,050 6% 8,522 8,050 6% 10%, price of 4% and Case mix /pa

  16. Slide 16: Inpatients Revenue Mix H1FY27

    Inpatients Revenue Mix H1FY27 IPS Paed Transplts Uro PSU & Govt 3% 3% Cardio 6% Nephro 4% 18% 9% 4% Self Pay Obs&Gynac 4% Gen Surg 4% 39% 7% Inpatient Inpatient Others Specialty Mix Payor Mix 17% Onco* 8% Internal Med 10% 46% 7% Gastro 11% Neuro Insurance Ortho * Oncology includes Radiotherapy and C

  17. Slide 17: Healthcare Services: Expansion Plan

    Healthcare Services: Expansion Plan Commissioned 5 new hospitals (~1,000 Census beds) Beds Total Census Project Cost Location Nature Beds Beds (in Crs) Commissioned Of the total ~1,000 Census beds, excluding Gurgaon, (Census) 520 beds have been operationalized, with the FY26 - FY27 Pune (Phase 1 & P

  18. Slide 18: Healthcare Services: Operational Snapshot

    Healthcare Services : Operational Snapshot Metros: Chennai, Hyderabad, Bangalore, Mumbai, Kolkata and NCR Q2FY27 6 Metros Non Metros Non Metros (includes Tier1 & Tier2 cities) Ahmedabad, Bhubaneshwar, Lucknow, Operating Indore, Guwahati, Madurai, Trichy, 4,966 3,556 Nellore,Vizag, Kakinada, Mysore,

  19. Slide 19: Tamil Nadu Region

    Tamil Nadu Region Metro:- Chennai ; Non Metro:- Madurai, Karur, Karaikudi, Trichy and Nellore Nellore Nellore Chennai Tamil Nadu Region Q2FY27 Q2FY26 YoY H1FY27 H1FY26 YoY Operating Beds 2,005 2,066 -3.0% 2,005 2,066 -3.0% Bed Occupancy Rate (%) 72% 63% 71% 62% Trichy Inpatient volume 44,707 39,356

  20. Slide 20: AP, Telangana Region

    AP, Telangana Region Metro:- Hyderabad; Non Metro:- Karimnagar, Vizag and Kakinada Vishakhapatnam AP, Telangana Region Q2FY27 Q2FY26 Q2FY26 YoY H1FY27 H1FY26 YoY Operating Beds 1,447 1,290 12.2% 1,447 1,290 12.2% Bed Occupancy Rate (%) 71% 68% 68% 65% Inpatient volume 31,289 25,592 22.3% 60,327 48,8

  21. Slide 21: Karnataka Region

    Karnataka Region Metro:- Bangalore; Non Metro:- Mysore Karnataka Region Q2FY27 Q2FY26 YoY H1FY27 H1FY26 YoY Operating Beds 881 781 12.8% 881 781 12.8% Bed Occupancy Rate (%) 70% 70% 68% 69% Inpatient volume 20,579 17,765 15.8% 39,216 34,718 13.0% Inpatient ALOS (days) 2.75 2.83 -3.1% 2.78 2.85 -2.5%

  22. Slide 22: Eastern Region

    Eastern Region Metro:- Kolkata; Non Metro:- Guwahati, Bhubaneshwar, Bilaspur and Rourkela Eastern Region Q2FY27 Q2FY26 YoY H1FY27 H1FY26 YoY Guwahati Operating Beds 1,983 1,818 9.1% 1,983 1,818 9.1% Bed Occupancy Rate (%) 77% 79% 75% 75% Inpatient volume 40,742 36,361 12.0% 78,110 69,678 12.1% Inpat

  23. Slide 23: Western Region

    Western Region Metro:- Mumbai; Non Metro:- Nashik, Ahmedabad and Pune Western Region Ahmedabad Q2FY27 Q2FY26 YoY H1FY27 H1FY26 YoY Operating Beds 965 888 8.7% 965 888 8.7% Bed Occupancy Rate (%) 67% 60% 62% 56% Inpatient volume 17,819 14,929 19.4% 33,189 28,026 18.4% Nashik Inpatient ALOS (days) 3.3

  24. Slide 24: Northern Region

    Northern Region Metro:- NCR; Non Metro:- Lucknow and Indore Delhi Northern Region Q2FY27 Q2FY26 YoY H1FY27 H1FY26 YoY Lucknow Operating Beds 1,241 1,207 1,241 1,207 2.8% 2.8% Bed Occupancy Rate (%) 77% 72% 75% 71% Inpatient volume 30,844 28,981 6.4% 59,849 56,338 6.2% Inpatient ALOS (days) 2.83 2.75

  25. Slide 25: Diagnostics & Retail Health, Apollo Health & Lifestyle Ltd

    • Diagnostics & Retail Health Apollo Health & Lifestyle Ltd © 2026 Apollo Hospitals Enterprise Ltd, All Rights Reserved 24

  26. Slide 26: Executive Summary

    Executive Summary Primary Care Diagnostics Specialty Care ~A J.A '"'poIIo o·ta I y:s1s ., Clinics Apollo DIAGNOSTICS ® gl)A Apollo S~~~1 ~m • Specialists in Surgery ~ Cradte &Children's Hospital ltollo Fertility  Core Primary Care revenue grew ~5% YoY in  Net addition of 5 Labs & 416 Collection 

  27. Slide 27: AHLL Financials Q2FY27

    AHLL Financials Q2FY 27 (` mio) Primary Corporate / Discontinuing Diagnostics Specialty Care AHLL Care Intra Group operations Revenue 1387 2269 841 -202 0 4294 AHLL revenue & EBITDA grew by 20% & EBITDA 305 360 133 -183 0 615 79% YoY in Q2 FY27 respectively; Q2 FY27 margin (%) 22% 16% 16% - - 14% pr

  28. Slide 28: AHLL Financials H1FY27

    AHLL Financials H1FY 27 (` mio) Primary Corporate / Discontinuing Diagnostics Specialty Care AHLL Care Intra Group operations Revenue 2652 4272 1645 -398 0 8172 EBITDA 550 640 257 -392 0 1056 AHLL revenue & EBITDA grew by 19% & H1 FY27 margin (%) 21% 15% 16% - - 13% 83% YoY in H1 FY27 respectively;

  29. Slide 29: Diagnostics: Key Parameters

    Diagnostics : Key Parameters Gross Revenue (INR Mn) EBITDA (INR Mn)1 Operational footprint (as of September 30, 2026) 14% 16% 14% 12.0% ~473+ 10.8% ~330+ Cities Cities presence 2,269 360 1,939 2,003 presence 1,827 1,768 273 281 +24% YoY 220 191 +64% YoY 1 Q2 FY26 Q3 FY26 Q4 FY26 Q1 FY27 Q2 FY27 120

  30. Slide 30: Digital Health & Pharmacy Distribution, Apollo HealthCo

    Digital Health & Pharmacy • Distribution Apollo HealthCo © 2026 Apollo Hospitals Enterprise Ltd, All Rights Reserved 29

  31. Slide 31: India's Largest Omni-Channel Healthcare Platform

    India’s Largest Omni-Channel Healthcare Platform Apollo 247 Digital Platform Apollo Pharmacy Platform 7,662 Stores ~15.3% Omni Private ~51 Mn+ Registrations n hi Manish • Added (Q2) 223 label / generics Chandigarh: 4 mix ,r; ,>JI Closed (Q2) 1 - Q2’FY27 Book Apollo Doctor Appoinlmc,nl Himachal Prade

  32. Slide 32: Apollo HealthCo Financials Q2 FY27

    Apollo HealthCo Financials Q2 FY27 (` mio) HealthCo (Q2’ FY27 vs Q2’ FY26) Online Offline o Digital became cash positive to Rs 13 Mn in Q2’FY27, reduction in losses by Rs 400 Mn YoY Pharmacy Total ` Mio Pharmacy Distribution & HealthCo o Health Co Revenue growth @25% growth in Q2’ FY27 vs Q2’ FY26 e

  33. Slide 33: Apollo HealthCo Financials H1 FY27

    Apollo HealthCo Financials H1 FY27 (` mio) Health Co (H1’ FY27 vs H1’ FY26) Online Offline Pharmacy Total o Health Co Revenue growth @23% growth in H1’ FY27 vs H1’ FY26 excluding closure of non ` Mio Pharmacy Distribution & HealthCo profitable corporate partner (Offline PD @ 23%, and Online PD + Apo

  34. Slide 34: Apollo HealthCo: Composite Scheme approved by Shareholders

    Apollo HealthCo: Composite Scheme as approved by the Shareholders : 24th June 2026 Undertaking below transactions sequentially, via a scheme of arrangement • Demerger of Omnichannel pharmacy distribution (OCP) and Apollo 24|7 digital platform (shares of Step 1 AHEL in Apollo Healthco Ltd) & remote t

  35. Slide 35: Composite scheme: Resultant Shareholding Structure

    Composite scheme: Resultant Shareholding Structure as approved by Shareholders 15% + 2.5%** AHEL Keimed promoters and Other SH Estimated Listing by 25.3% AHEL 42.1% Q4FY27 post all Shareholders approvals. Advent ESOP 12.1% 3.0% Effective AHEL plus AHEL shareholders combined • Automatic listing of Ne

  36. Slide 36: Combined Proforma Financial Metrics (Proposed New Co) H1FY27

    Combined Proforma Financial Metrics (Proposed New Co) H1FY27 (` mio) H1’FY27 Combined Combined Offline Pharma Online Pharma Combined Distribution Total Healthco Keimed FY25 FY26 Distribution+247 H1’FY27 Revenue 1,63,772 1,90,366 55,132 7,496 62,628 86,567 1,12,015 EBITDA,Pre 11,180 13,749 3,856 1,47

  37. Slide 37: Annexure

    • Annexure © 2026 Apollo Hospitals Enterprise Ltd, All Rights Reserved 36

  38. Slide 38: Basis of Consolidation

    Basis of Consolidation AHEL AHEL Standalone Hospitals (100% Subsidiaries Location Description Ownership Ownership) Location Material Subs Chennai Main Chennai Apollo HealthCo Limited India Digital Omni-Channel Healthcare services Platform 98.07% ACI - Chennai Chennai Apollo Health and Lifestyle Ltd

  39. Slide 39: IND AS 116: Impact on P&L and Balance Sheet H1FY27

    IND AS - 116 : Impact on P&L and Balance Sheet –H1FY27 (` mio) AHEL Standalone (post IND AS 116) AHEL Consolidated (post IND AS 116) Balance sheet Profit & Loss Balance sheet Profit & Loss Right of use Asset Revenue Right of use Asset Revenue as of 13,693 as of 25,964 30 September, Other expenses 81

  40. Slide 40: Thank you

    Thank you 39

Apollo Hospitals Enterprise — Q2 FY27 Earnings Presentation on 6ix